Company Profile · Healthcare

Bruker Corporation

BRKR · US
Exchange
US
Country
USA
IPO date
Aug 4, 2000
Employees
11,085
Current Price
$60.05
Live · Jul 27, 2026
Fair Buy
≤ $48
Margin-of-safety entry
Baillie Growth Score
41/100
Weak
Intrinsic Value · Three-Tier Range Current price $60.05 Live · Between the fair and optimistic ranges

Composite valuation range · conservative $35–$45 / fair $48–$60 / optimistic $68–$85. At $60.05, Between the fair and optimistic ranges.

At publication $59.97 (Jun 4, 2026)

Market cap$9.2B
Revenue (TTM)$3.46B
EBITDA$488.7M
Profit margin-0.34%
ROE-0.43%
Forward P/E15.22
PEG1.52
EPS-$0.24
Dividend yield0.32%
52-week range$28.39 – $64.48
Analyst target$59.75
Analyst rating3.9 / 5

Data from EODHD, shown in the reporting currency; for reference only, not investment advice.

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.